CONFERENCE UPDATES: ACC 2026

FFRangio demonstrates non-inferiority to pressure wire based physiologic assessment in intermediate coronary lesions: Results from the ALL-RISE randomized trial

20 May 2026
Get access to our exclusive articles.
Related Articles

AI-created digital twins of vertebra predict the vertebral fracture risk IN SM patients

It is projected that there will be 1.9 million new cancer diagnoses and over 600,000 cancer deaths in 2022 in the United States alone.1 Spine is the most common site for bone metastasis; up to 70% of cancer patients could experience spinal metastasis (SM) and about 20% of them become symptomatic, causing considerable pain and morbidity.2 Most common regions for SM are dorsal (45%), lumbar (17%), cervical (14%), and dorsolumbar (10%).3 Vertebral fractures (VFs) are the common complications of SM, with an estimation of 30% of patients developing VFs that mostly require surgery.4 Tumor lesions and some treatments for cancer can lead to loss of bone tissue, thus increasing the risk of VFs.5 Hence, it is imperative to predict the VF risk in SM patients, so that well-informed interventions can be designed.5 Factors influencing VFs include both the macro- and micro-structure of the vertebra, especially of the trabecula.5 In-vitro methods are used to study the biomechanical forces that alter the vertebral shape, but they cannot accurately measure in-vivo stresses that damage its microstructure.5 The development of computational modeling has made it a compelling tool for measuring these in-vivo stressors.5 A recent study by Ahmadian et al was to assess the feasibility of the artificial intelligence (AI)-assisted framework to create ‘digital twins’ of the human vertebra, termed ReconGAN, to predict the VF risk in both osteolytic and osteoblastic metastatic tumors.5

08 Jul 2022